BioSpace News Archive

Policy

Covid News Brief: Vaccine Boosters, Profits, Treatment Updates and More

With expectations that the U.S. FDA will announce a decision about booster shots for the Moderna and Johnson & Johnson vaccines this week, there is plenty of COVID-19-related news. Here’s a look.

October 19, 2021
·
5 min read
·
Mark Terry
Drug Development

Delta Has Been Brutal: How the Deadliest Covid Variant Has Affected the World

The Delta variant is the deadliest variant of the coronavirus, and according to the CDC, this variant has the highest transmission rate yet.

October 19, 2021
·
6 min read
·
Mishayl Hanan
Drug Development

Gene Therapy Redosing Gains Traction as Need Grows and Novel Strategies Emerge

Redosing is a large and growing concern for gene therapy developers and regulators.

October 19, 2021
·
4 min read
·
Gail Dutton
Deals

Boehringer Ingelheim Steps Up to the Plate for Cystic Fibrosis Patients

Choosing to exercise its options with a group of research and development partners, the pharma giant will accelerate a promising new C.F. gene therapy.

October 19, 2021
·
2 min read
·
Kate Goodwin
ObsEva Announces Presentation of Clinical Data on Oral GnRH Antagonist Linzagolix at ASRM 2021 Scientific Congress & Expo

ObsEva SA announced two upcoming poster presentations on linzagolix, an oral GnRH antagonist, at the American Society for Reproductive Medicine 2021 Scientific Congress & Expo, being held October 17-20, 2021.

October 19, 2021
·
3 min read
Policy

Hyloris Announces Approval of Maxigesic® IV in the UK and Ireland

Hyloris Pharmaceuticals SA announces further extension of the European footprint of Maxigesic® IV, a novel, unique combination of 1000mg paracetamol and 300mg ibuprofen solution for infusion, for the treatment of post-operative pain.

October 19, 2021
·
3 min read
InnoCare Announces Approval of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 in China

InnoCare Pharma announced that the Company has received Investigational New Drug approval from the NMPA for its SHP2 allosteric inhibitor ICP-189, which is the company’s 9th innovative drug candidate entering clinical development.

October 19, 2021
·
1 min read
Atorvastatin Drug Market: Increase in Pevalence of Hypercholesterolemia is a Key Factor Driving the Market

Atorvastatin is a class of prescription medicine called HMG-CoA reductase inhibitors (statins), which lowers the low density proteins (LDL) cholesterol and triglycerides in the blood.

October 19, 2021
·
5 min read
Over US$ 3.5 Bn Incremental Opportunity to be created in Lewy Body Dementia Treatment Market as Incidence of Alzheimer’s Continues Rising

Fact.MR – A Market Research and Competitive Intelligence Provider: The global Lewy Body Dementia treatment market is projected to surpass a valuation of US$ 3,500.5 Mn between 2018 and 2028, according to newly released data by Fact.MR.

October 19, 2021
·
8 min read
Biotechnology Instruments Market is anticipated to Experience Growth Opportunities to 2030

Biotechnology Instruments Market growth is on the back of the increasing adoption of point-of-care diagnostic devices.

October 19, 2021
·
4 min read